Abstract
Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Current Medicinal Chemistry
Title: Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection
Volume: 11 Issue: 4
Author(s): John D. Noti
Affiliation:
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Abstract: Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Export Options
About this article
Cite this article as:
Noti D. John, Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection, Current Medicinal Chemistry 2004; 11 (4) . https://dx.doi.org/10.2174/0929867043455945
DOI https://dx.doi.org/10.2174/0929867043455945 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Clinical and Computational Analysis of Variants Associated with Rare Genetic Disorders
This thematic issue focuses on integrating clinical insights and computational techniques in the study of genetic variants linked to rare genetic disorders. Rare diseases, while individually uncommon, collectively affect millions of people worldwide, making their understanding and diagnosis critical to personalized medicine. Advances in next-generation sequencing (NGS) and bioinformatics tools ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endothelin and the Ischaemic Heart
Current Vascular Pharmacology Recent Advances and Patents on Coronary Sinus Perfusion Devices for Treatment of Heart Disease
Recent Patents on Biomedical Engineering (Discontinued) Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Evaluation of Plasma Homocysteine Levels as a Prognostic Factor for the Occurrence of Perioperative Myocardial Infarction in Coronary Artery Bypass Grafting: A Pilot Study
Vascular Disease Prevention (Discontinued) A Novel Approach to the Old Issue of Ischemic Nephropathy
Current Vascular Pharmacology The Heme-Heme Oxygenase System in Wound Healing; Implications for Scar Formation
Current Drug Targets Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats
Current Molecular Medicine Metabolic Syndrome X is a Low-Grade Systemic Inflammatory Condition with its Origins in the Perinatal Period
Current Nutrition & Food Science Extracellular Hsp70: Export and Function
Current Protein & Peptide Science MicroRNA-21: From Cancer to Cardiovascular Disease
Current Drug Targets Prostacyclin Synthase Gene: Implication and Prevention of Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Thematic Issue: Vascular Damage In Systemic Sclerosis)
Current Rheumatology Reviews A Novel Danshensu-Tetramethylpyrazine Conjugate DT-018 Provides Cardioprotection by Preserving Mitochondrial Function Through the MEF2D/PGC-1α Pathway
Current Pharmaceutical Design Combination of Contrast-enhanced FlAIR and Contrast-enhanced T1WI: A Quick and Efficient Method in Detecting Brain Metastases of Lung Cancers
Current Medical Imaging Polyphenols in Disease: from Diet to Supplements
Current Pharmaceutical Biotechnology Gamma-mangostin Protects S16Y Schwann Cells Against <i>tert</i>-Butyl Hydroperoxide-induced Apoptotic Cell Death
Current Pharmaceutical Design Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Recent Advances in Characterizing Natural Products that Regulate Autophagy
Anti-Cancer Agents in Medicinal Chemistry Improvement of a Novel Proposal for Antioxidant Treatment Against Brain Damage Occurring in Ischemic Stroke Patients
CNS & Neurological Disorders - Drug Targets